Kathleen S. Capps serves as Executive at ENANTA PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Kathleen S. Capps has executed 4 insider transactions totaling $7.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 5, 2025 involved selling 323 shares valued at $4.6K.
Kathleen S. Capps currently holds 8,377 shares of ENANTA PHARMACEUTICALS INC (ENTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kathleen S. Capps has been a net seller of ENTA stock. They have purchased $0 and sold $7.5K worth of shares.
Kathleen S. Capps's most recent insider trade was on Dec 5, 2025, when they sold 323 shares at $14.23 per share.
Get notified when new Form 4 filings are submitted
| $13.96 |
| Discretionary |
| Dec 1, 2025 | ENTA | $1.2K | Payment | 85 | $14.12 | Discretionary |
| Nov 25, 2025 | ENTA | $0 | Award | 3,163 | $N/A | Discretionary |